NEW YORK (GenomeWeb) – The Association of Community Cancer Centers (ACCC), a cancer care provider advocacy group, announced today that Pfizer will provide $1.5 million in grant funding to support initiatives integrating BRCA testing into patient care plans.

The funding, which is being provided under the Pfizer Independent Grants for Learning and Change program, will provide up to $150,000 to individual grant awardees. It is only available to ACCC-member cancer programs and practices.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.